SPONSOR
Zhujiang Hospital
Total Trials
10
Recruiting
10
Phases
Phase 2, Phase 3, Phase 2, Phase 1, Phase 2
Conditions studied: Chronic GlomerulonephritisChronic Kidney DiseaseHepatocellular Carcinoma (HCC)Locally Advanced Oral Squamous Cell CarcinomaCotinine LevelsArterial Aneurysm Wall Enhancement on HRMRINSCLC Diagnosed by Histology or CytologyA Multidisciplinary Team Assessment Determined That the Patient Was a Suitable Candidate for Radical Surgical ResectionOverall Lung Function is Adequate for the Planned Lung ResectionAJCC is Classified as IIA-IIIB
Zhujiang Hospital is a clinical research sponsor with 10 registered studies on ClinicalTrials.gov, of which 10 are actively recruiting participants. Research covers conditions including Chronic Glomerulonephritis, Chronic Kidney Disease, Hepatocellular Carcinoma (HCC), Locally Advanced Oral Squamous Cell Carcinoma.
The trial portfolio spans Phase 2, Phase 3, Phase 2, Phase 1, Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Zhujiang Hospital
How many clinical trials has Zhujiang Hospital sponsored?
ClinicalMetric currently tracks 10 clinical trials sponsored by Zhujiang Hospital, of which 10 are actively recruiting participants. These trials cover conditions including Chronic Glomerulonephritis, Chronic Kidney Disease, Hepatocellular Carcinoma (HCC). Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Zhujiang Hospital research focus on?
Zhujiang Hospital clinical trials span Chronic Glomerulonephritis, Chronic Kidney Disease, Hepatocellular Carcinoma (HCC), Locally Advanced Oral Squamous Cell Carcinoma, Cotinine Levels, and additional conditions. The research pipeline includes Phase 2, Phase 3, Phase 2, Phase 1, Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Zhujiang Hospital clinical trial?
To participate in a Zhujiang Hospital trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Zhujiang Hospital trials with current recruitment status updated daily.
Clinical Trials by Zhujiang Hospital
NCT07330362
Recruiting
The Clinical Application of Artificial Intelligence Assisted Renal Biopsy Diagnosis System.
Chronic Glomerulonephritis
NCT06644937 Phase 2, Phase 3
Recruiting
Single-arm Clinical Trial of TACE in Combination With Icaritin as Adjuvant Therapy After Surgery in Patients With Hepatocellular Carcinoma at High Risk of Recurrence
Hepatocellular Carcinoma (HCC)
NCT07111455
Recruiting
Prospective Cohort Study on Oral Microbiome Changes in Patients With Locally Advanced Oral Squamous Cell Carcinoma Following Neoadjuvant Chemoimmunotherapy
Locally Advanced Oral Squamous Cell Carcinoma
NCT06447714
Recruiting
A Study on the Correlation Between Cotinine Levels and Aneurysm Wall Enhancement on HRMRI.
Cotinine Levels
NCT07534033 Phase 2
Recruiting
Phase II Clinical Study of Probiotic LR607 in Patients With Non-Small Cell Lung Cancer
NSCLC Diagnosed by Histology or Cytology
NCT05462366
Recruiting
Omics Sequencing of Specimen Derived From Mother-Infant-Pairs
Healthy
NCT06341400 Phase 1, Phase 2
Recruiting
RC48 Combined With Toripalimab as Neoadjuvant Therapy for Cisplatin Ineligible MIBC Patients
Bladder Cancer
NCT06456814
Recruiting
Epidemiological Insights Into the Formation, Progression, and Rupture of Intracranial Aneurysms: A Retrospective, Multi-Center Hospital-Based Study in China
Intracranial Aneurysm
NCT06712004 Phase 2
Recruiting
A Dose-Response Controlled Trial of Bevifibatide for Acute Ischemic Stroke
Ischemic Stroke, Acute
NCT06539767
Recruiting
Risk Assessment and Mechanism Analysis of Intracranial Multiple Aneurysm Instability Based on High-resolution Magnetic Resonance, Imaging Histology and Hemodynamics
Arterial Aneurysm Wall Enhancement on HRMRI
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology